|
Randomized Trial of Diabetic Patients in India Finds Paclitaxel-Eluting Stents Failed to Meet Non-Inferiority Compared to Everolimus-Eluting Stents
|
|
Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents in High Bleeding Risk Patients with One Month DAPT
|
|
Assessing Fractional Flow Reserve Using Computed Tomography Shown to Reduce Costs in Patients with Chest Pain
|
|
Thrombus Aspiration During PCI Shows No Benefit to Standard PCI in STEMI Patients Presenting Late After Symptom Onset
|
|
Clinical Trial Confirms No Late Benefit for Routine Thrombus Aspiration in STEMI Patients
|
|
Medical Therapy with Ranolazine did not Reduce Adverse Events in Patients with Persistent Untreated Heart Artery Blockages after Percutaneous Coronary Intervention
|
|
First-in-Man Study Examines Angiographic and Clinical Outcomes of Newest Bioresorbable Magnesium Stent
|
|
Two-Year Data from the First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes
|
|
Clinical Trial Demonstrates that a Bioresorbable Scaffold is Non-Inferior to a Drug-eluting Stent in Patients with Coronary Artery Disease
|
|
Clinical Trial Demonstrates that a Bioresorbable Scaffold is Non-Inferior to a Drug-Eluting Stent in Chinese Patients with Coronary Artery Disease
|
